Benzinga Korea 한국
Benzinga Korea 한국
Comments

Viking Therapeutics 내부자 거래 활동

VKTXNASDAQ
Benzinga Data가 제공하는 로고
대중과의 거래
대중과의 거래
$36.15
-0.93-2.51%
가까이에: Dec 15, 4:00 PM EST
$36.24
0.090.25%
시간외: 7:54 PM EST
개요뉴스실적옵션분석가 평가

내부자 거래

매도 수량주식 보고서

내부자 거래 움직임

최신 Viking Therapeutics 내부자 거래 활동을 추적하세요. Viking Therapeutics 주식에 대한 최근 매수, 매도 및 시장 영향에 대한 정보를 받아보세요.

내부자 활동이란 무엇입니까?

내부자 거래 활동에는 임원, 이사, 직원 등 회사 내부자가 자신의 회사 주식을 거래하는 행위가 포함됩니다. 내부자의 구매 및 판매 거래는 회사의 미래 성과에 대한 신뢰에 대한 귀중한 통찰력을 제공합니다.

Viking Therapeutics Inc 내부자는 무엇을 하고 있나요?

내부자들은 지난 30일 동안 구매/판매가 없다고 보고했습니다.

주목할만한 최근 내부자 구매 및 판매

지난 90일 동안 내부자 구매 또는 판매가 없습니다.

소유권 통계 Viking Therapeutics Inc

발행 주식
113.036M
내부자 보유 주식
4.488M
내부자 보유 비율
3.97%
기관 보유 주식
41.332M
기관 보유 비율
36.6%
Oct 28, 2025Marianna ManciniCHIEF OPERATING OFFICER4.93K$35.00-$216.49KGRANT1.31%382.47KOct 27 - Oct 28View
Oct 28, 2025Charles Rowland Jr—0.00$20.34-$1.83MGRANT0.00%30.00KOct 27View
Oct 28, 2025Brian LianPRESIDENT & CEO31.09K$35.01-$1.36MGRANT1.30%2.42MOct 27 - Oct 28View
Oct 28, 2025GREG ZANTECHIEF FINANCIAL OFFICER4.93K$35.00-$216.48KGRANT2.92%173.59KOct 27 - Oct 28View
Jul 03, 2025Brian LianPRESIDENT & CEO21.44K$27.80-$747.63KGRANT0.91%2.39MJul 02 - Jul 03View
Jul 03, 2025GREG ZANTECHIEF FINANCIAL OFFICER3.40K$27.76-$118.43KGRANT2.06%168.66KJul 02 - Jul 03View
Jul 03, 2025Marianna ManciniCHIEF OPERATING OFFICER3.40K$27.77-$118.47KGRANT0.91%377.54KJul 02 - Jul 03View
Apr 02, 2025Kathryn Sarah Rouan—1.24K$24.15$29.94KBUY∞1.24KMar 31View
Jan 06, 2025Brian LianPRESIDENT & CEO61.64K$42.75-$8.31MGRANT2.67%2.37MJan 03 - Jan 06View
Jan 06, 2025Marianna ManciniCHIEF OPERATING OFFICER11.98K$42.75-$2.32MGRANT3.31%374.13KJan 03 - Jan 06View
Jan 06, 2025GREG ZANTECHIEF FINANCIAL OFFICER15.89K$42.75-$2.15MGRANT10.64%165.26KJan 03 - Jan 06View
Nov 08, 2024LAWSON MACARTNEY—0.00$37.23-$125.73KSELL-OPTIONS0.00%47.97KNov 08View
Oct 28, 2024GREG ZANTECHIEF FINANCIAL OFFICER-37.69K$42.05-$9.38MSELL-20.15%149.37KOct 28View
Oct 25, 2024Kathryn Sarah Rouan—0.00$42.88-$836.11KSELL-OPTIONS0.00%0.00Oct 25View
Oct 25, 2024MATTHEW SINGLETON—0.00$41.99-$1.20MSELL-OPTIONS0.00%9.50KOct 25View
Sep 20, 2024MATTHEW SINGLETON—0.00$35.34-$703.59KSELL-OPTIONS0.00%9.50KSep 20View
Sep 20, 2024Brian LianPRESIDENT & CEO-50.00K$39.30-$14.02MSELL-2.12%2.30MSep 20View
Aug 22, 2024Brian LianPRESIDENT & CEO0.00$38.84-$62.13KSELL-OPTIONS0.00%2.35MAug 21View
Aug 22, 2024MATTHEW SINGLETON—0.00$35.46-$390.65KSELL-OPTIONS0.00%9.50KAug 21View
Aug 19, 2024Brian LianPRESIDENT & CEO0.00$36.78-$6.55MSELL-OPTIONS0.00%2.35MAug 19View
Aug 19, 2024MATTHEW SINGLETON—0.00$32.77-$942.17KSELL-OPTIONS0.00%9.50KAug 19View
Aug 14, 2024MATTHEW SINGLETON—0.00$32.76-$1.03MSELL-OPTIONS0.00%9.50KAug 14View
Jul 31, 2024GREG ZANTECHIEF FINANCIAL OFFICER12.20K$57.15-$922.21KGRANT6.98%187.05KJul 29 - Jul 30View
Jul 31, 2024Marianna ManciniCHIEF OPERATING OFFICER13.64K$57.13-$1.03MGRANT3.91%362.15KJul 29 - Jul 30View
Jul 31, 2024Brian LianPRESIDENT & CEO88.47K$57.58-$6.67MGRANT3.90%2.35MJul 29 - Jul 30View
May 03, 2024GREG ZANTECHIEF FINANCIAL OFFICER-32.51K$39.77-$4.82MSELL-15.68%174.85KMay 03View
May 02, 2024Marianna ManciniCHIEF OPERATING OFFICER0.00$42.42-$20.40MSELL-OPTIONS0.00%348.51KMay 01View
Feb 09, 2024Brian LianPRESIDENT & CEO-45.00K$29.90-$1.35MSELL-2.06%2.14MFeb 09View
Feb 08, 2024Brian LianPRESIDENT & CEO-80.00K$15.32-$6.52MSELL-3.53%2.18MFeb 08View
Feb 08, 2024Kathryn Sarah RouanDIRECTOR0.00$18.19-$493.25KSELL-OPTIONS0.00%0.00Feb 08View
Jan 31, 2024Brian LianPRESIDENT & CEO0.00$12.97-$2.00MSELL-OPTIONS0.00%2.26MJan 31View
Jan 30, 2024Brian LianPRESIDENT & CEO0.00$12.59-$795.20KSELL-OPTIONS0.00%2.26MJan 30View
Jan 19, 2024Kathryn Sarah RouanDIRECTOR0.00$15.69-$441.90KSELL-OPTIONS0.00%0.00Jan 19View
Jan 04, 2024GREG ZANTECHIEF FINANCIAL OFFICER20.34K$17.71-$1.38MGRANT12.68%180.73KJan 03 - Jan 04View
May 18, 2023Charles Rowland JrDIRECTOR0.00$13.04-$956.80KSELL-OPTIONS0.00%30.00KMay 16View
May 18, 2023LAWSON MACARTNEYDIRECTOR0.00$12.60-$364.96KSELL-OPTIONS0.00%47.97KMay 16View
May 01, 2023Brian LianPRESIDENT & CEO-45.00K$22.45-$1.01MSELL-2.01%2.20MMay 01View
Apr 24, 2023LAWSON MACARTNEYDIRECTOR0.00$12.67-$298.78KSELL-OPTIONS0.00%47.97KApr 24View
Apr 21, 2023Brian LianPRESIDENT & CEO-35.00K$21.45-$750.75KSELL-1.54%2.24MApr 19View
Apr 18, 2023LAWSON MACARTNEYDIRECTOR0.00$14.00-$249.43KSELL-OPTIONS0.00%47.97KApr 17View
Apr 18, 2023Brian LianPRESIDENT & CEO-30.00K$11.30-$2.90MSELL-1.30%2.28MApr 17View
Apr 18, 2023Marianna ManciniCHIEF OPERATING OFFICER0.00$16.54-$86.63KSELL-OPTIONS0.00%287.76KApr 17View
Apr 18, 2023GREG ZANTECHIEF FINANCIAL OFFICER0.00$16.54-$51.98KSELL-OPTIONS0.00%149.28KApr 17View
Apr 13, 2023Brian LianPRESIDENT & CEO-25.00K$10.16-$1.36MSELL-1.07%2.31MApr 13View
Apr 13, 2023GREG ZANTECHIEF FINANCIAL OFFICER0.00$11.79-$1.22MSELL-OPTIONS0.00%149.28KApr 11 - Apr 12View
Apr 03, 2023Brian LianPRESIDENT & CEO60.00K$11.10-$6.75MSELL-OPTIONS2.64%2.33MMar 30 - Apr 03View
Apr 03, 2023GREG ZANTECHIEF FINANCIAL OFFICER-35.78K$12.35-$2.83MSELL-19.33%149.28KMar 30 - Apr 03View
Mar 30, 2023Marianna ManciniCHIEF OPERATING OFFICER-55.38K$9.05-$3.07MSELL-17.45%261.89KMar 28 - Mar 29View
May 03, 2022MATTHEW FOEHRDIRECTOR45.00K$2.47$111.19KBUY67.92%111.25KMay 02View
Jun 10, 2021MATTHEW FOEHRDIRECTOR20.00K$5.69$113.80KBUY43.24%66.25KJun 10View
Aug 27, 2020LIGAND PHARMACEUTICALS INC—-164.49K$8.07-$1.33MSELL-2.75%5.82MAug 25 - Aug 26View
Jun 30, 2020MATTHEW FOEHR—-13.00K$7.35-$95.55KSELL-33.12%26.25KJun 30View
Sep 27, 2018LIGAND PHARMACEUTICALS INC10% OWNER-262.88K$19.15-$5.03MSELL-4.17%6.04MSep 25View
May 31, 2018MATTHEW SINGLETONDIRECTOR9.50K$9.82$93.26KBUY∞9.50KMay 31View
May 31, 2018Michael MorneauVP, FINANCE AND ADMINISTRATION-21.55K$9.25-$199.35KSELL-18.64%94.03KMay 31View
May 31, 2018Charles Rowland JrDIRECTOR30.00K$5.16$154.80KBUY∞30.00KMay 29View
May 31, 2018Stephen WebsterDIRECTOR8.00K$5.21$41.71KBUY∞8.00KMay 29View
May 31, 2018LAWSON MACARTNEYDIRECTOR47.97K$5.22$250.33KBUY∞47.97KMay 29View
Nov 15, 2016MATTHEW FOEHRDIRECTOR13.00K$1.21$15.68KBUY49.52%39.25KNov 15View
Apr 13, 2016MATTHEW FOEHRDIRECTOR20.00K$1.24$24.80KBUY320.00%26.25KApr 13View
May 05, 2015MATTHEW FOEHRDIRECTOR6.25K$8.00$50.00KBUY∞6.25KMay 04View

FAQ

Q

인사이더 트레이딩은 합법인가요?

A
인사이더 트레이딩은 인사이더가 그 거래를 SEC에 보고하는 한 합법입니다. 불법 증권 거래는 인사이더가 위임된 의무를 위반하거나 거래를 보고하지 않을 때 발생합니다.
Q

시장 조작의 몇 가지 예는 무엇인가요?

A
인사이더 트레이딩, 펌프 앤 덤프 계획, 프론트 러닝 및 워시 트레이드는 모두 시장 조작의 예입니다. 인사이더 자산 이동을 추적하는 투자자들은 이들 인사이더가 주식을 거래하는 이유에 대해 신중히 고려해야 합니다.

검색 내부자 거래 모든 주식에 대한

사람들이 또한 지켜본다

Immunovant Inc
NASDAQ:IMVT
$26.00
%
Legend Biotech Corp
NASDAQ:LEGN
$22.10
0.41%
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
$36.83
1.66%
Celcuity Inc
NASDAQ:CELC
$102.18
%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
$26.15
%
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
$29.40
1.55%
Alkermes PLC
NASDAQ:ALKS
$28.23
0.21%
Xenon Pharmaceuticals Inc
NASDAQ:XENE
$43.60
%
Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2025 Benzinga | All Rights Reserved